Advertisement

Topics

A New Audio Interview With Jackie D. Williams Jr, CEO of AppYea, Inc. is Now at SmallCapVoice.com

20:00 EDT 1 Jun 2015 | Globe Newswire

AUSTIN, Texas, June 2, 2015 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and AppYea Inc. (OTCQB:APYP) (the Company), a global mobile application developer for iOS, Google Play, and Amazon platforms, announced today that a new audio interview with the Company, is now available. The interview can be heard at http://smallcapvoice.com/blog/5-27-15-smallcapvoice-interview-with-appyea-inc-apyp

Jackie D. Williams Jr, CEO of AppYea, Inc. called in to SmallCapVoice.com to provide the listening audience with a comprehensive overview of the Company's history, unique business model as well as his own candid insights into the goals for the Company in 2015.

"Our Company has come a long way in a short amount of time and we know that our investors want to hear from us about our future plans," stated Williams. "We appreciate the opportunity to share our story with our shareholders and the SmallCapVoice.com listening audience."

About SmallCapVoice.com

SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.

About AppYea, Inc

AppYea, Inc., founded in 2012, is a global mobile application developer for iOS, Google Play, and Amazon platforms. The Company operates its own titles as well as provides strategic partnerships with promising mobile app developers. AppYea focuses on a number of different categories including next-generation social networks and gaming. The company is headquartered in Ft Worth, Texas. The Company's common stock trades on the OTCQB, under the ticker symbol "APYP."

Find out more by visiting: http://appyea.com/about/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.

CONTACT: AppYea Inc.
         Jackie D. Williams Jr., CEO
         info@appyea.com
         777 Main Street Ste 600
         Fort Worth, Texas 76102
         Phone: (817) 887-8142
         Phone: (855) 927-7932 FREE
         Website http://www.appyea.com
         
         For SmallCapVoice.com
         Stuart T. Smith
         512-267-2430
         info@smallcapvoice.com

SmallCapVoice.com Logo

NEXT ARTICLE

More From BioPortfolio on "A New Audio Interview With Jackie D. Williams Jr, CEO of AppYea, Inc. is Now at SmallCapVoice.com"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.